Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Press

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The Oncologist|June 23, 2010
Major molecular response in CML patients treated with tyrosine kinase inhibitors: the paradigm for monitoring targeted cancer therapyRichard D Press
Clinical Advances in Hematology & Oncology : H&O|July 9, 2014
Clinical implementation of next-generation sequencingRichard D Press
Leukemia & Lymphoma|July 15, 2016
Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practicesRanjana Arora, Richard D Press
Expert Review of Molecular Diagnostics|September 26, 2013
BCR-ABL PCR testing in chronic myelogenous leukemia: molecular diagnosis for targeted cancer therapy and monitoringMartin H Luu, Richard D Press
Molecular Diagnosis & Therapy|December 19, 2019
Clinical Utility of Next-Generation Sequencing in Acute Myeloid LeukemiaFei Yang, Tauangtham Anekpuritanang, Richard D Press
The Journal of Molecular Diagnostics : JMD|July 2, 2013
BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemiaRichard D Press, Suzanne Kamel-Reid, Daphne Ang
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2013
Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemiaFranklin R Moore, Fei Yang, Richard D Press
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2015
The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipientsMorgan Hakki, Rogan M Rattray, Richard D Press
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2013
Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemiaFranklin R Moore, Carole B Rempfer, Richard D Press
Clinical Chemistry|March 11, 2004
Quantitative real-time PCR with automated sample preparation for diagnosis and monitoring of cytomegalovirus infection in bone marrow transplant patientsKyeong Man Hong, Hazim Najjar, Mary Hawley, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The Oncologist|June 23, 2010
Major molecular response in CML patients treated with tyrosine kinase inhibitors: the paradigm for monitoring targeted cancer therapyRichard D Press
Clinical Advances in Hematology & Oncology : H&O|July 9, 2014
Clinical implementation of next-generation sequencingRichard D Press
Leukemia & Lymphoma|July 15, 2016
Measurement of BCR-ABL1 transcripts on the International Scale in the United States: current status and best practicesRanjana Arora, Richard D Press
Expert Review of Molecular Diagnostics|September 26, 2013
BCR-ABL PCR testing in chronic myelogenous leukemia: molecular diagnosis for targeted cancer therapy and monitoringMartin H Luu, Richard D Press
Molecular Diagnosis & Therapy|December 19, 2019
Clinical Utility of Next-Generation Sequencing in Acute Myeloid LeukemiaFei Yang, Tauangtham Anekpuritanang, Richard D Press
The Journal of Molecular Diagnostics : JMD|July 2, 2013
BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemiaRichard D Press, Suzanne Kamel-Reid, Daphne Ang
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2013
Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemiaFranklin R Moore, Fei Yang, Richard D Press
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2015
The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipientsMorgan Hakki, Rogan M Rattray, Richard D Press
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2013
Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemiaFranklin R Moore, Carole B Rempfer, Richard D Press
Clinical Chemistry|March 11, 2004
Quantitative real-time PCR with automated sample preparation for diagnosis and monitoring of cytomegalovirus infection in bone marrow transplant patientsKyeong Man Hong, Hazim Najjar, Mary Hawley, et al.
Pageof 6